Home›Stock Screener›FDC›Quarterly Results

FDC Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹103 Cr
QMar 2026
Quarterly Results

In Mar 2026, FDC (FDC) reported revenue ₹635 Cr and net profit ₹103 Cr — revenue +25.0% YoY. Analyse FDC FII DII holdings to track promoter, FII and institutional holdings.

FDC Quarterly Results — Revenue, Profit & EPS Highlights

FDC latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View FDC 52-week performance for the annual high/low range and current price position.

  • Revenue of ₹635 Cr in Mar 2026 (-11.2% vs Jun 2026, +25.0% vs Mar 2025)
  • Net Profit of ₹103 Cr in Mar 2026 (-22.6% vs Jun 2026, +164.1% vs Mar 2025)
  • EBITDA of ₹156 Cr in Mar 2026 (-18.3% vs Jun 2026)
  • Operating Margin of 18.0% in Mar 2026 (-3.0pp vs Jun 2026)
  • Earnings Per Share of ₹6.35 in Mar 2026 (-22.0% vs Jun 2026)

FDC Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FDC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 635 715 494 508 684 -11.2% 25.0%
Net Profit (₹ Cr) 103 133 28 39 121 - -
EBITDA (₹ Cr) 156 191 54 70 176 - -
EPS (₹) 6.35 8.14 1.75 2.38 7.45 - -
Operating Margin (%) 18.0% 21.0% 7.0% 11.0% 22.0% - -

FDC Share Price Trend — 1-Year Movement Across Quarterly Results

FDC 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit FDC stock price BSE.

Profitability Ratios

Profit Margin 16.2%
EBITDA Margin 24.6%
Operating Margin 18.0%
ROE (Annual) 16.6%

Balance Sheet Highlights

Total Assets ₹2,919 Cr
Total Equity ₹2,485 Cr
Current Assets ₹1,133 Cr
Current Liabilities ₹70 Cr

Cash Flow Analysis

Operating Cash Flow ₹200 Cr
Investing Cash Flow ₹-110 Cr
Financing Cash Flow ₹-93 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹352.50
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 508
Sept 2025 494
Jun 2026 715
Mar 2026 635

Net Profit Trend (₹ Cr)

Mar 2025 39
Sept 2025 28
Jun 2026 133
Mar 2026 103

Operating Margin Trend (%)

Mar 2025 11.0%
Sept 2025 7.0%
Jun 2026 21.0%
Mar 2026 18.0%

FDC vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

FDC latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores